Jianshi Technology-B (09877): Jensclip has submitted an application for CE certification registration

Zhitong Finance App News, Jianshi Technology-B (09877) issued an announcement. Recently, the company has officially submitted a CE certification registration application for the company's mitral valve repair (TMVR) system. This is another product that the company successfully submitted a CE certification registration application after the catheter tricuspid valve replacement system Lux-Valve Plus. It is an important process in the company's internationalization strategy.

JensClip is an innovative medical device designed to treat severe mitral valve reflux. The device is easy to operate and reliable. Its claw wedge mechanical locking design can be locked at any angle to ensure stable and reliable valve alignment. It is expected to effectively improve mitral valve reflux and reduce valve tension. Its diamond-shaped valve clip design is easy to recover and reposition, making cross-valve operation safer, and effectively improving surgical safety and ease of operation; its integrated dissociation design is expected to reduce the risk of potential misoperation during fractional dissection and effectively shorten instrument operation time. JensClip's innovative design has been patented around the world.

JensClip's one-year clinical follow-up results and challenge case application experience were presented at international academic conferences such as EuroPCR, TCT San Francisco, and PCR London Valves in 2025. Its safety indicators and efficacy indicators all performed excellently and received widespread attention.

At present, JensClip has completed the submission and acceptance of the China Drug Administration registration application in China. The results of the one-year follow-up are excellent, and it is currently in the registration review stage. JensClip has also successfully launched clinical applications overseas. The company will actively promote the registration process for this product to meet a wide range of clinical needs.